PhytoXtract SA holds an authorisation from Swissmedic, the Swiss Agency for Therapeutic Products, for the manufacture (GMP) and distribution (GDP) of medicinal products. All tasks relating to manufacture and analysis of our products are carried out in accordance with the … Read More
contact b2b@phytoxtract.ch for more information… Read More
[EN] Swiss Medical Cannabis : PhytoXtract SA is the 1st Laboratory to be granted GMP/GDP authorisations in Romandy, Switzerland. Plan-les-Ouates, 05.01.2021 – PhytoXtract SA is granted both GMP (Good Manufacturing Practices) and GDP (Good Distribution Practices) from Swissmedic – Swiss … Read More
[EN] 01.02.2020 – PhytoXtract SA will be focusing on Medical Cannabis and therefore selling part of its company and brand porfolio Plan-les-Ouates, 01.02.2020 – PhytoXtract SA is selling one of its brand “Cannaliz” and subsidiairy PhytoCloud SA in order to … Read More
On this page, you can find the safety data sheet for the products classified as chemicals, such as: CBD oils [EN] Huile CBD [FR]
[yith_ywraq_request_quote]
[woocommerce_datatranscw]
This page summarizes the classification of the products on sale on this website for the Swiss market, and is as such an integral part of the general terms and conditions of sale for Switzerland. Accordingly, when a sale of products … Read More
Products sold and the contents on this website are produced with the greatest care. Products are however neither retaken, nor exchanged. We listen to our customers, and care to understand their needs; do not hesitate to contact us. When ordering/purchasing … Read More
Disclaimer: The products listed below are intended exclusively for use by professionals [b2b customers] who are authorized to dispense these products.
